Skip to content

Establishment of pharmacovigilance and monitoring system for the use of statins in patients with ischemic stroke

Establishment of pharmacovigilance and monitoring system for the use of statins in patients with ischemic stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093774
Enrollment
Unknown
Registered
2024-12-11
Start date
2023-01-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Pharmacovigilance Management Group:Guide the patient before and after the first medication, and monitor the patients clinical symptoms and indicators after the medication throughout the hospitalizatio
Control group:No clinical pharmacist intervention.

Sponsors

Jingjiang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Entry criteria: 1.Patient age>18 years old; 2.For patients with acute ischemic stroke diagnosed for the first time, the examination after admission meets the diagnostic criteria for acute ischemic stroke, and is finally confirmed by CT or MRI.; 3.The patient or his family members sign an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1.Non-first acute ischemic stroke; 2.Have taken statins or Bette drugs within 1 month before the onset of the disease; 3.Malignant tumors, chronic liver disease, active liver disease, liver and kidney insufficiency, elevated alanine aminotransferase (greater than 3 times the normal upper limit), severe renal insufficiency (creatinine clearance rate <30ml/min), myopathy; 4.Patients with a life expectancy of less than 3 months or unable to complete the study for other reasons; 5.Patients that other researchers believe are not suitable for participating in the study.

Design outcomes

Primary

MeasureTime frame
Liver function;Myocardial enzyme;

Countries

China

Contacts

Public ContactGuang-Yu Zhao

Jingjiang People's Hospital

zhaoguangyu2000@sina.com+86 150 5290 6318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026